Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
Main Authors: | Alamgeer, Muhammad, Ganju, Vinod, Kumar, Beena, Fox, Jane, Hart, Stewart, White, Michelle, Harris, Marion, Stuckey, John, Prodanovic, Zdenka, Schneider-Kolsky, Michal Elisabeth, Watkins, D Neil |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053180/ |
Similar Items
-
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
by: Alamgeer, Muhammad, et al.
Published: (2013) -
The Evolution of Therapies in Non-Small Cell Lung Cancer
by: Boolell, Vishal, et al.
Published: (2015) -
SAXS fingerprints of aldehyde dehydrogenase oligomers
by: Tanner, John J.
Published: (2015) -
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
by: Tiezzi, Daniel Guimarães, et al.
Published: (2013) -
Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
by: Patil, Vijay M., et al.
Published: (2016)